Physician profile
Joshua M Gitlin
NPI 1730241555
$8,444.14
in general payments reported to CMS, 2019-2025
46 companies · $1,489 in 2025
The $1,489 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2020: $644 · 2021: $897 · 2022: $859 · 2023: $1,618 · 2024: $1,710 · 2025: $1,489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,816.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,708.65 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $906.44 | 2019-2025 | Xtampza, Belbuca |
| Globus Medical, INC. | $765.39 | 2025 | Senza, Vyrsa V1 |
| Abbvie INC. | $492.60 | 2022-2025 | |
| Abbott Laboratories | $427.76 | 2019-2025 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $386.19 | 2019-2023 | Ztlido |
| Medtronic USA, INC. | $380.18 | 2019-2020 | |
| Vertos Medical, INC. | $343.41 | 2021-2024 | Mild Device Kit |
| Boston Scientific Corporation | $277.15 | 2019-2025 | Intracept |
| Nalu Medical, INC. | $272.99 | 2022-2025 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $230.48 | 2020-2024 | Sprint Pns System |
| Medtronic, INC. | $227.08 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Amgen INC. | $223.80 | 2019-2022 | |
| Saluda Medical Americas, INC. | $213.95 | 2023-2025 | Evoke Scs, Evoke |
| Allergan, INC. | $187.98 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Gitlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.